Novel transcription factor, bp1
CA 2381863 A1 · Owner: Berg, Patricia E. · Inventors: Berg, Patricia E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An isolated DNA of SEQ ID NO: 1 is provided that encodes the transcription factor BP1, which is believed to be a repressor of the .beta.-globin gene. A host cell that is transformed with a vector that contains the DNA may be used to produce BP1. Vectors having a controllable promoter operably connected to the BP1 open reading frame may be used to transform .beta.-globin producing cells of patients with sickle cell anemia thereby providing a treatment. , Because BP1 is overexpressed in leukemia and breast cancer cells,acute myeloid leukemia, acute lymphocytic leukemia, and breast cancer can be screened for and diagnosed by determining whether PB1is overexpressed in cell samples of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 14, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 14, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 14, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.